Product/Composition:- | Lidocaine injectable |
---|---|
Strength:- | 1%, 2%, 5% |
Form:- | Injectable |
Reference Brands:- | Xylocaine, Lidocaine Plus(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Lidocaine injectables block sodium channels in nerve cells, preventing nerve signal transmission and providing localized anesthesia. Benefits include rapid onset of numbness, effective pain relief during surgical and diagnostic procedures, minimal systemic effects, and versatility for various medical applications, ensuring safe, targeted, and quick pain management when used properly.
Lidocaine injectable is approved in the EU and US for local anesthesia and pain management in surgical and diagnostic procedures. In the EU, brands like Xylocaine are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and adherence to manufacturing standards, with strict pharmacovigilance. Both regions enforce rigorous controls due to the risk of misuse and toxicity. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lidocaine injectables, ensuring adherence to European and American standards for safe, effective anesthetic use while navigating complex regulatory landscapes seamlessly.